Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptomics reveals the role of Macrophage-Naïve CD4 + T cell interaction in the immunosuppressive microenvironment of primary liver carcinoma. | J Transl Med | 2022 | 36221095 | PubTator, text mining | PubMed |
| Gaucher Disease: An Unusual Cause of Knee Pain. | J Am Acad Orthop Surg Glob Res Rev | 2022 | 36219694 | PubTator, text mining | PubMed |
| Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension. | Front Immunol | 2022 | 36211384 | PubTator, text mining | PubMed |
| Prognostic value of TIGIT in East Asian patients with solid cancers: A systematic review, meta-analysis and pancancer analysis. | Front Immunol | 2022 | 36211383 | PubTator, text mining | PubMed |
| Applications of machine learning in tumor-associated macrophages. | Front Immunol | 2022 | 36211379 | PubTator, text mining | PubMed |
| Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer. | Front Immunol | 2022 | 36211375 | PubTator, text mining | PubMed |
| S-nitrosylation of CSF1 receptor increases the efficacy of CSF1R blockage against prostate cancer. | Cell Death Dis | 2022 | 36209194 | PubTator, text mining | PubMed |
| Mechanoresponsive regulation of fibroblast-to-myofibroblast transition in three-dimensional tissue analogues: mechanical strain amplitude dependency of fibrosis. | Sci Rep | 2022 | 36207437 | PubTator, text mining | PubMed |
| Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage. | Nat Commun | 2022 | 36195613 | PubTator, text mining | PubMed |
| The role of macrophage subtypes and exosomes in immunomodulation. | Cell Mol Biol Lett | 2022 | 36192691 | PubTator, text mining | PubMed |
| Increased mast cell activation in eosinophilic chronic obstructive pulmonary disease. | Clin Transl Immunology | 2022 | 36188122 | PubTator, text mining | PubMed |
| The DPY30-H3K4me3 Axis-Mediated PD-L1 Expression in Melanoma. | J Inflamm Res | 2022 | 36185638 | PubTator, text mining | PubMed |
| Tracking the Stability of Clinically Relevant Blood Plasma Proteins with Delta-S-Cys-Albumin-A Dilute-and-Shoot LC/MS-Based Marker of Specimen Exposure to Thawed Conditions. | Mol Cell Proteomics | 2022 | 36182099 | PubTator, text mining | PubMed |
| GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma. | J Clin Lab Anal | 2022 | 36181310 | PubTator, text mining | PubMed |
| A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma. | Nat Commun | 2022 | 36180422 | PubTator, text mining | PubMed |
| Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction. | Front Immunol | 2022 | 36177003 | PubTator, text mining | PubMed |
| Macrophage-extracellular matrix interactions: Perspectives for tissue engineered heart valve remodeling. | Front Cardiovasc Med | 2022 | 36176991 | PubTator, text mining | PubMed |
| The influence of baseline characteristics on the efficacy of immune checkpoint inhibitors for advanced lung cancer: A systematic review and meta-analysis. | Front Pharmacol | 2022 | 36176428 | PubTator, text mining | PubMed |
| Nanoengineering facilitating the target mission: targeted extracellular vesicles delivery systems design. | J Nanobiotechnology | 2022 | 36175866 | PubTator, text mining | PubMed |
| Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy. | Theranostics | 2022 | 36168626 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=56